Jennifer F.
- Country
- Germany
- Department
- Neurology
Research Overview
- A DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED TRIAL TO ASSESS SAFETY AND EFFICACY OF SLS-005 (TREHALOSE INJECTION, 90.5 MG/ML FOR INTRAVENOUS INFUSION) FOR THE TREATMENT OF ADULTS WITH SPINOCEREBELLAR ATAXIA
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecal VO659 in Spinocerebellar Ataxia Types 1, 3, and Huntington's Disease
Data & Insights
Has run more than one trial at 1 of 18 partner sites.
Specializations
Neurological Disorders
This investigator specializes in the treatment and research of spinocerebellar ataxia, with particular focus on SCA1 and SCA3 variants. Their work extends to other neurodegenerative conditions, including Huntington's disease.
- Spinocerebellar Ataxia Type 1
- Spinocerebellar Ataxia Type 3
- Huntington's Disease
The investigator explores innovative therapeutic approaches for these rare neurological conditions.
Treatment Development
Their research encompasses the evaluation of novel intrathecal treatments and investigational compounds for neurological disorders. The investigator's work includes studying lumbar bolus administration techniques for therapeutic delivery.
- Intrathecal Drug Administration
- Novel Therapeutic Compounds
- Treatment Safety Assessment
The focus includes investigating both safety profiles and therapeutic efficacy in adult populations.
Clinical Assessment
The investigator conducts research in pharmacokinetics and pharmacodynamics of experimental treatments for neurodegenerative disorders. Their work involves evaluating therapeutic responses in adult patients with genetic neurological conditions.
- Treatment Safety Evaluation
- Tolerability Assessment
- Therapeutic Response Monitoring
Their clinical assessments focus on determining both safety parameters and treatment effectiveness.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.